Maravai LifeSciences Q1 Earnings Call Highlights
MarketBeat
Maravai LifeSciences (NASDAQ:MRVI) reported first-quarter fiscal 2026 results that management said marked a “strong start to 2026,” driven by growth at its TriLink segment, steady contribution from Cygnus, and the impact of restructuring actions taken last year.
On the company’s earnings call, CEO
NASDAQ:MRVI